| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0008 |